SEARCH

SEARCH BY CITATION

References

  • 1
    Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Tjonneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, et al. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2008; 98: 157481.
  • 2
    Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst 1994; 86: 2816.
  • 3
    Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 2005; 97: 176877.
  • 4
    Kesse E, Bertrais S, Astorg P, Jaouen A, Arnault N, Galan P, Hercberg S. Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) study. Br J Nutr 2006; 95: 53945.
  • 5
    Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 2008; 17: 9307.
  • 6
    Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994; 5: 27682.
  • 7
    Michaud DS, Augustsson K, Rimm EB, Stampfer MJ, Willet WC, Giovannucci E. A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 2001; 12: 55767.
  • 8
    Mitrou PN, Albanes D, Weinstein SJ, Pietinen P, Taylor PR, Virtamo J, Leitzmann MF. A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland). Int J Cancer 2007; 120: 246673.
  • 9
    Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Chao A, Patel AV, Thun MJ, Calle EE. Meat consumption among Black and White men and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2006; 15: 21116.
  • 10
    Rohrmann S, Platz EA, Kavanaugh CJ, Thuita L, Hoffman SC, Helzlsouer KJ. Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study. Cancer Causes Control 2007; 18: 4150.
  • 11
    Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, Schatzkin A, Cross AJ. Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol 2009; 170: 116577.
  • 12
    Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of prostate cancer: a prospective study of 25,708 Norwegian men. Int J Cancer 1997; 73: 6348.
  • 13
    Qin LQ, Xu JY, Wang PY, Kaneko T, Hoshi K, Sato A. Milk consumption is a risk factor for prostate cancer: meta-analysis of case–control studies. Nutr Cancer 2004; 48: 227.
  • 14
    Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 2001; 23: 8792.
  • 15
    Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 2001; 23: 7281.
  • 16
    Key TJ. Diet, insulin-like growth factor-1 and cancer risk. Proc Nutr Soc 2011: 14.
  • 17
    Brown PJ, Mei G, Gibberd FB, Burston D, Mayne PD, McClinchy JE, Sidey M. Diet and Refsum's disease. The determination of phytanic acid and phytol in certain foods and the application of this knowledge to the choice of suitable convenience foods for patients with Refsum's disease. J Hum Nutr Diet 1993; 6: 295305.
  • 18
    van den Brink DM, Wanders RJ. Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci 2006; 63: 175265.
  • 19
    Wanders RJ, Jansen GA, Skjeldal OH. Refsum disease, peroxisomes and phytanic acid oxidation: a review. J Neuropathol Exp Neurol 2001; 60: 102131.
  • 20
    Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM. α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287: 166270.
  • 21
    Xu J, Thornburg T, Turner AR, Vitolins M, Case D, Shadle J, Hinson L, Sun J, Liu W, Chang B, Adams TS, Zheng SL, et al. Serum levels of phytanic acid are associated with prostate cancer risk. Prostate 2005; 63: 20914.
  • 22
    Price AJ, Allen NE, Appleby PN, Crowe FL, Jenab M, Rinaldi S, Slimani N, Kaaks R, Rohrmann S, Boeing H, Pischon T, Benetou V, et al. Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2010; 91: 176976.
  • 23
    Allen NE, Grace PB, Ginn A, Travis RC, Roddam AW, Appleby PN, Key T. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids. Br J Nutr 2008;99: 6539.
  • 24
    The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 110.
  • 25
    The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 102935.
  • 26
    Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort—accuracy and delay. Acta Oncol 2002; 41: 3818.
  • 27
    Beahrs OH, American Joint Committee on Cancer, American Cancer Society, National Cancer Institute (U.S.). Manual for staging of cancer, 4th edn. Philadelphia: Lippincott, 1992.
  • 28
    Pietinen P, Hartman AM, Haapa E, Rasanen L, Haapakoski J, Palmgren J, Albanes D, Virtamo J, Huttunen JK. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988; 128: 65566.
  • 29
    Milne DB, Botnen J. Retinol, α-tocopherol, lycopene, and α- and β-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986; 32: 8746.
  • 30
    Willett WC. Nutritional epidemiology, 2nd edn. New York : Oxford University Press, 1998.
  • 31
    Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr 2003; 77: 53243.
  • 32
    Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control 2000; 11: 85967.
  • 33
    Verhoeven NM, Jakobs C. Human metabolism of phytanic acid and pristanic acid. Prog Lipid Res 2001; 40: 45366.
  • 34
    Zomer AW, van Der Burg B, Jansen GA, Wanders RJ, Poll-The BT, van Der Saag PT. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. J Lipid Res 2000; 41: 18017.
  • 35
    Schonfeld P, Struy H. Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria. FEBS Lett 1999; 457: 17983.
  • 36
    Mobley JA, Leav I, Zielie P, Wotkowitz C, Evans J, Lam YW, L'Esperance BS, Jiang Z, Ho SM. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev 2003; 12: 77583.
  • 37
    International Dairy Federation. The World Dairy Situation. Bulletin 423/2007. Brussels: International Dairy Federation, 2007.
  • 38
    Steinberg D. Phytanic acid storage disease (Refsum's disease). In: Stanbury JB, Wyngarden JB, Fredericksen DS, Goldstein JI, Brown MS, eds. Metabolic basis of inherited disease, 5th edn. New York: McGraw Hill, 1983: 731747.
  • 39
    Crowe FL, Key TJ, Appleby PN, Travis RC, Overvad K, Jakobsen MU, Johnsen NF, Tjonneland A, Linseisen J, Rohrmann S, Boeing H, Pischon T, et al. Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2008; 87: 140513.
  • 40
    Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993; 85: 15719.
  • 41
    Schatzkin A, Kipnis V. Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 2004; 96: 15645.
  • 42
    Mayne ST. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research. J Nutr 2003; 133 ( Suppl 3): 933S940S.